Literature DB >> 16119975

Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Maria T Herdeiro1, Adolfo Figueiras, Jorge Polónia, Juan Jesus Gestal-Otero.   

Abstract

OBJECTIVES: Voluntary adverse drug reaction (ADR) reporting is fundamental to medical drug safety surveillance; however, substantial under-reporting exists and is the main limitation of the system. This study sought to identify the knowledge- and attitude-related factors associated with ADR reporting by physicians in Northern Portugal.
METHODS: Case-control study covering a population of National Health Service medical practitioners. The 88 cases comprised physicians who had reported at least one ADR to the drug surveillance unit from the year 2000 to the date of enrolment in the study. The 771 controls were randomly selected from among the remaining physicians. All interviews were conducted using a self-administered questionnaire. Knowledge and attitudes regarding spontaneous ADR reporting were based on Inman's 'seven deadly sins'. Agreement with the questions included in the questionnaire was measured using a horizontal, continuous visual analogue scale, which was unnumbered. Recorded answers were read in a range from zero (total disagreement) to ten (total agreement). We used logistic regression to determine the ADR reporting adjusted odds ratio (ORadj) for a change in exposure corresponding to the interquartile range for each attitude.
RESULTS: A total of 397 questionnaires were received from 731 eligible practitioners (54.3%). Physicians who worked in primary versus hospital care (ORadj 7.74 [95% CI 1.85, 32.30]) and in general medicine (ORadj 1.05 [95% CI 0.30, 3.69]) versus medical specialities were more likely to report ADRs. In contrast, physicians working in the medical-surgical/surgical fields were significantly less likely to report ADRs compared with medical specialists (ORadj 0.10 [95% CI 0.02, 0.46]). Attitudes to ADRs were strongly associated with reporting probability. Hence, an interquartile decrease in any of the following attitudes increased the probability of reporting by: (i) 87% (p < 0.05) for complacency (the belief that really serious ADRs are well documented by the time a drug is marketed); (ii) 109% (p < 0.01) for insecurity (the belief that it is nearly impossible to determine whether a drug is responsible for a particular adverse reaction); (iii) 143% (p < 0.001) for diffidence (the belief that one would only report an ADR if one were sure that it was related to the use of a particular drug); (iv) 220% (p < 0.001) for indifference (the belief that the one case an individual doctor might see could not contribute to medical knowledge); and (v) 71% (p < 0.05) for ignorance (the belief that it is only necessary to report serious or unexpected ADRs).
CONCLUSION: This study shows that there are attitudes strongly associated with under-reporting. The implementation of purpose-designed educational interventions based on the attitudes identified in this study may serve to improve reporting substantially.

Entities:  

Mesh:

Year:  2005        PMID: 16119975     DOI: 10.2165/00002018-200528090-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  40 in total

Review 1.  Pharmacovigilance in perspective.

Authors:  R H Meyboom; A C Egberts; F W Gribnau; Y A Hekster
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

2.  Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.

Authors:  A R Cox; J F Marriott; K A Wilson; R E Ferner
Journal:  J Clin Pharm Ther       Date:  2004-02       Impact factor: 2.512

3.  A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise.

Authors:  S Grant; T Aitchison; E Henderson; J Christie; S Zare; J McMurray; H Dargie
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 4.  Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.

Authors:  María T Herdeiro; Jorge Polonia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  J Eval Clin Pract       Date:  2004-11       Impact factor: 2.431

5.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

6.  Attitudes to adverse drug reaction reporting.

Authors:  W H Inman
Journal:  Br J Clin Pharmacol       Date:  1996-05       Impact factor: 4.335

7.  Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.

Authors:  M Cosentino; O Leoni; F Banfi; S Lecchini; G Frigo
Journal:  Pharmacol Res       Date:  1997-02       Impact factor: 7.658

8.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

9.  [Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians].

Authors:  G Serrano Cózar; C Esteban Calvo; J A Gijón Porta; I Vaquero Turiño; M I Vázquez Burgos; C Ibáñez Ruiz; J Frías Iniesta
Journal:  Aten Primaria       Date:  1997-04-15       Impact factor: 1.137

Review 10.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

View more
  55 in total

1.  Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.

Authors:  Ingrid Oosterhuis; Florence P A M van Hunsel; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).

Authors:  Chiara Biagi; Nicola Montanaro; Elena Buccellato; Giuseppe Roberto; Alberto Vaccheri; Domenico Motola
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

3.  Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.

Authors:  Maria Teresa Herdeiro; Inês Ribeiro-Vaz; Mónica Ferreira; Jorge Polónia; Amílcar Falcão; Adolfo Figueiras
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

4.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

5.  A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India.

Authors:  Suparna Chatterjee; Nazmun Lyle; Souvik Ghosh
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.

Authors:  Marta Irujo; Guadalupe Beitia; Maira Bes-Rastrollo; Adolfo Figueiras; Sonia Hernández-Díaz; Berta Lasheras
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor.

Authors:  Susanna M Wallerstedt; Gertrud Brunlöf; Marie-Louise Johansson; Carina Tukukino; Lars Ny
Journal:  Eur J Clin Pharmacol       Date:  2007-03-09       Impact factor: 2.953

Review 9.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Authors:  Consuelo Pedrós; Antoni Vallano; Gloria Cereza; Gemma Mendoza-Aran; Antònia Agustí; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep M Arnau
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.